Literature DB >> 32093292

NADPH Oxidase Overactivity Underlies Telomere Shortening in Human Atherosclerosis.

Álvaro Pejenaute1,2, Adriana Cortés1,2, Javier Marqués1,2, Laura Montero1, Óscar Beloqui2,3, Ana Fortuño4, Amelia Martí2,5, Josune Orbe2,4, Guillermo Zalba1,2.   

Abstract

Telomere shortening and oxidative stress are involved in the pathogenesis of atherosclerosis. Different studies have shown that phagocytic NADPH oxidase is associated with this disease. This study aimed to investigate the association between phagocytic NADPH oxidase and telomere shortening in human atherosclerosis. To assess this potential association, telomere length and phagocytic NADPH oxidase activity were determined by PCR and chemiluminescence, respectively, in a population of asymptomatic subjects free of overt clinical atherosclerosis. We also measured serum 8-hydroxy-2-deoxyguanosine (8-OHdG) levels (an index of oxidative stress) and carotid intima-media thickness (IMT), a surrogate marker of atherosclerosis. After adjusting them for age and sex, telomere length inversely correlated (p < 0.05) with NADPH oxidase-mediated superoxide production, with 8-OHdG values, and with carotid IMT. Interestingly, the asymptomatic subjects with plaques have a lower telomere length (p < 0.05), and higher values of plasma 8-OHdG and superoxide production (p < 0.05). These data were confirmed in a second population in which patients with coronary artery disease showed lower telomere length and higher 8-OHdG and superoxide production than the asymptomatic subjects. In both studies, NADPH oxidase-dependent superoxide production in phagocytic cells was only due to the specific expression of the Nox2 isoform. In conclusion, these findings suggest that phagocytic NADPH oxidase may be involved in oxidative stress-mediated telomere shortening, and that this axis may be critically involved in human atherosclerosis.

Entities:  

Keywords:  NADPH oxidase; atherosclerosis; intima-media thickness; oxidative stress; telomere length

Year:  2020        PMID: 32093292     DOI: 10.3390/ijms21041434

Source DB:  PubMed          Journal:  Int J Mol Sci        ISSN: 1422-0067            Impact factor:   5.923


  7 in total

Review 1.  NADPH oxidase family proteins: signaling dynamics to disease management.

Authors:  Rizwana Begum; Shilpa Thota; Abubakar Abdulkadir; Gagandeep Kaur; Prathyusha Bagam; Sanjay Batra
Journal:  Cell Mol Immunol       Date:  2022-05-18       Impact factor: 22.096

2.  gp91phox, a Novel Biomarker Evaluating Oxidative Stress, Is Elevated in Subclinical Hypothyroidism.

Authors:  Xiaochun Ma; Furong Wang; Xiaowen Zhen; Lifang Zhao; Li Fang; Zhenfang Dong; Wenbin Chen; Xiaoming Zhou
Journal:  Int J Endocrinol       Date:  2020-05-06       Impact factor: 3.257

3.  Assessment of the Telomere Length and Its Effect on the Symptomatology of Parkinson's Disease.

Authors:  Tina Levstek; Sara Redenšek; Maja Trošt; Vita Dolžan; Katarina Trebušak Podkrajšek
Journal:  Antioxidants (Basel)       Date:  2021-01-19

Review 4.  Leukocyte Telomere Length as a Molecular Biomarker of Coronary Heart Disease.

Authors:  Olga V Zimnitskaya; Marina M Petrova; Natalia V Lareva; Marina S Cherniaeva; Mustafa Al-Zamil; Anastasia E Ivanova; Natalia A Shnayder
Journal:  Genes (Basel)       Date:  2022-07-12       Impact factor: 4.141

5.  Interleukin 32 participates in cardiomyocyte-induced oxidative stress, inflammation and apoptosis during hypoxia/reoxygenation via the NOD2/NOX2/MAPK signaling pathway.

Authors:  Yuanyuan Li; Zhongyan Wang
Journal:  Exp Ther Med       Date:  2022-07-12       Impact factor: 2.751

Review 6.  Effect of Omega-3 Fatty Acids on Telomeres-Are They the Elixir of Youth?

Authors:  Magdalena Ogłuszka; Paweł Lipiński; Rafał R Starzyński
Journal:  Nutrients       Date:  2022-09-09       Impact factor: 6.706

7.  Leukocyte telomere length, allelic variations in related genes and risk of coronary heart disease in people with long-standing type 1 diabetes.

Authors:  Manuel Sanchez; Caroline Kannengiesser; Sophie Hoang; Louis Potier; Frédéric Fumeron; Nicolas Venteclef; André Scheen; Jean-François Gautier; Samy Hadjadj; Michel Marre; Ronan Roussel; Kamel Mohammedi; Gilberto Velho
Journal:  Cardiovasc Diabetol       Date:  2022-10-11       Impact factor: 8.949

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.